Literature DB >> 23751435

Advances in the management of thyroid eye disease.

César A Briceño, Shivani Gupta, Raymond S Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23751435      PMCID： PMC3711216          DOI： 10.1097/IIO.0b013e318293c44e

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  25 in total

1.  The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota.

Authors:  G B Bartley; V Fatourechi; E F Kadrmas; S J Jacobsen; D M Ilstrup; J A Garrity; C A Gorman
Journal:  Am J Ophthalmol       Date:  1995-10       Impact factor: 5.258

2.  Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture.

Authors:  A Sorisky; D Pardasani; A Gagnon; T J Smith
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

3.  Rituximab for thyroid eye disease.

Authors:  Rona Z Silkiss; Alice Reier; Morton Coleman; Simeon A Lauer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Sep-Oct       Impact factor: 1.746

4.  Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy.

Authors:  Noortje I Regensburg; Wilmar M Wiersinga; Tos T J M Berendschot; Peerooz Saeed; Maarten P Mourits
Journal:  Thyroid       Date:  2010-12-12       Impact factor: 6.568

5.  Selenium and the course of mild Graves' orbitopathy.

Authors:  Claudio Marcocci; George J Kahaly; Gerasimos E Krassas; Luigi Bartalena; Mark Prummel; Matthias Stahl; Maria Antonietta Altea; Marco Nardi; Susanne Pitz; Kostas Boboridis; Paolo Sivelli; George von Arx; Maarten P Mourits; Lelio Baldeschi; Walter Bencivelli; Wilmar Wiersinga
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

6.  Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.

Authors:  Canan Gürdal; Ipek Genç; Ozge Saraç; Ipek Gönül; Tamer Takmaz; Izzet Can
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

7.  A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Authors:  Seema Kumar; Reagan Schiefer; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

8.  Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.

Authors:  Lei Zhang; Timothy Bowen; Fiona Grennan-Jones; Carol Paddon; Peter Giles; Jason Webber; Robert Steadman; Marian Ludgate
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

Review 9.  Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.

Authors:  Terry J Smith; Chieh Chih Tsai; Mei-Ju Shih; Shanli Tsui; Beiling Chen; Rui Han; Vibha Naik; Chris S King; Chris Press; Shweta Kamat; Robert A Goldberg; Richard P Phipps; Raymond S Douglas; Andrew G Gianoukakis
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

10.  Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004.

Authors:  Martin Laclaustra; Ana Navas-Acien; Saverio Stranges; Jose M Ordovas; Eliseo Guallar
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031
View more
  6 in total

Review 1.  Thyroid eye disease: current and potential medical management.

Authors:  Jessica M Pouso-Diz; Jose M Abalo-Lojo; Francisco Gonzalez
Journal:  Int Ophthalmol       Date:  2020-01-09       Impact factor: 2.031

2.  Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease.

Authors:  Erick Rivera-Grana; Phoebe Lin; Eric B Suhler; James T Rosenbaum
Journal:  J Clin Exp Ophthalmol       Date:  2015-04-27

3.  Rituximab Treatment in a Patient with Active Graves' Orbitopathy and Psoriasis.

Authors:  Tülay Şimşek; Nilgün Yıldırım; Belgin Efe; Nur Kebapçı
Journal:  Turk J Ophthalmol       Date:  2017-01-17

Review 4.  Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface.

Authors:  Priscila Novaes; Ana Beatriz Diniz Grisolia; Terry J Smith
Journal:  Clin Diabetes Endocrinol       Date:  2016-11-16

5.  Ocular motility changes after inferomedial wall and balanced medial plus lateral wall orbital decompression in Graves' orbitopathy: a randomized prospective comparative study.

Authors:  Cristiane de Almeida Leite; Thaís de Sousa Pereira; Jeane Chiang; Rodrigo Bernal Moritz; Allan Christian Pieroni Gonçalves; Mário Luiz Ribeiro Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2021-04-09       Impact factor: 2.365

6.  Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

Authors:  Raymond S Douglas; Yao Wang; Roger A Dailey; Gerald J Harris; Sara T Wester; Jade S Schiffman; Rosa A Tang; Brian Fowler; James Fleming; Terry J Smith
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.